Mega Cap companies are those with a market capitalization of $200 billion or more. Most of these companies boast well-established business models, strong brand power, and global operations. Due to their sheer size, mega cap companies offer relatively higher protection from broader market fluctuations and are considered safe bets during uncertain macroeconomic times.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
A mega cap company usually offers regular dividend payments and has the potential to generate notable capital gains. Investors can help secure their portfolio returns by investing at least a portion of their funds into mega cap stocks.
Leveraging TipRanks’ Stock Screener, we have identified three mega cap stocks with Strong Buy consensus ratings from analysts. Furthermore, each stock boasts an Outperform Smart Score (i.e., 8, 9, or 10) on TipRanks, indicating they are highly likely to outperform market expectations. The Smart Score evaluates eight factors to gauge a stock’s potential to outperform the broader market.
Here are this week’s stocks:
AstraZeneca (AZN) – AstraZeneca is a British-Swedish biopharmaceutical giant focused on the development and commercialization of prescription drugs. The stock offers an attractive dividend yield of 3.05% and a Smart Score of “Perfect 10.” Over the last three months, all five Wall Street analysts covering AZN stock have rated it a Strong Buy, with their 12-month average AstraZeneca price target indicating an upside of 30.1%. AZN stock is up 6.5% so far this year.
Alibaba (BABA) – Alibaba is a Chinese e-commerce giant with advanced technological capabilities and a robust supply chain. The stock carries a dividend yield of 1.65% and a Smart Score of “Perfect 10.” Over the past three months, 14 Wall Street analysts covering BABA stock have rated it a Buy, while one analyst rated the stock a Hold. Combined, their 12-month average Alibaba price target indicates an upside of nearly 26.3%. BABA stock is up 44.2% year-to-date.
Abbott Laboratories (ABT) – Abbott Laboratories is a global healthcare company, selling medical devices, diagnostics, branded generic medicines, and nutritional products. ABT carries an attractive dividend yield of 1.91% and a Smart Score of “Perfect 10.” Over the past three months, 15 Wall Street analysts covering ABT stock have rated it a Buy, while three analysts rated the stock a Hold. Combined, their 12-month average Abbott Laboratories price target indicates an upside of 17.6%. Year-to-date, ABT stock is up 10.9%.
What Is TipRanks’ Smart Portfolio?
The TipRanks Smart Portfolio offers insights into the stocks you own and enables comprehensive portfolio analysis. It also allows you to compare your portfolio with those of other investors, including top performers. Interestingly, the tool has been upgraded to provide AI-generated explanations for each holding’s stock movements and to track all assets on your watchlist.
Like all TipRanks tools, Smart Portfolio is easy to use and helps you make data-driven investment decisions.